A phase II study of tinostamustine in patients (pts) with advanced solid tumours

被引：0
|
作者：
Tinker, Anna
Strauss, James Fredric
Schneider, Reva
Chugh, Rashmi
Curigliano, Giuseppe
Di Nicola, Massimo A.
Oaknin, Ana
Janik, Tomas
Hilgier, Kasia
Manamley, Nick
Kummar, Shivaani
机构：
[1] BC Canc Vancouver, Vancouver, BC, Canada
[2] Mary Crowley Canc Res, Dallas, TX USA
[3] Univ Michigan, Ann Arbor, MI USA
[4] Univ Milan, European Inst Oncol, IRCCS, Milan, Italy
[5] Fdn IRCCS Ist Nazl, Milan, Italy
[6] Hosp Univ Vall dHebron, Gynaecol Canc Programme, Vall dHebron Inst Oncol VHIO, Vall dHebron Barcelona Hosp Campus, Barcelona, Spain
[7] Mundipharma Res Ltd, Cambridge, England
[8] Oregon Hlth & Sci Univ, Div Hematol & Med Oncol, Portland, OR USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3021
引用
收藏
页数：1
相关论文
共 50 条
  • [11] Phase II randomised discontinuation trial of cabozantinib in patients with advanced solid tumours
    Schoffski, Patrick
    Gordon, Michael
    Smith, David C.
    Kurzrock, Razelle
    Daud, Adil
    Vogelzang, Nicholas J.
    Lee, Yihua
    Scheffold, Christian
    Shapiro, Geoffrey I.
    EUROPEAN JOURNAL OF CANCER, 2017, 86 : 296 - 304
  • [12] Results of a phase II study with sunitinilb malate (SU11248) in patients (pts) with advanced neuroendocrine tumours (NETs)
    Kulka, M.
    Lenz, H.
    Meropol, N.
    Posey, J.
    Picus, J.
    Ryan, D.
    Bergsland, E.
    Stuart, K.
    Baum, C.
    Fuchs, C.
    EJC SUPPLEMENTS, 2005, 3 (02): : 204 - 204
  • [13] Ezabenlimab (BI 754091) monotherapy in patients (pts) with advanced solid tumours
    Patel, M. R.
    Johnson, M. L.
    Winer, I.
    Arkenau, H-T.
    Cook, N.
    Samouelian, V.
    Aljumaily, R.
    Kitano, S.
    Duffy, C.
    Ge, M.
    Elgadi, M.
    Siu, L. L.
    ANNALS OF ONCOLOGY, 2021, 32 : S606 - S607
  • [14] PROPEL: A phase I/II trial of bempegaldesleukin (NKTR-214) in combination with pembrolizumab (pembro) in patients (pts) with advanced solid tumours
    Reck, M.
    Cappuzzo, F.
    Rodriguez-Abreu, D.
    Cho, D. C.
    Schwarz, J. K.
    Riese, M. J.
    Gupta, A.
    Chan, T.
    Saab, R.
    Singel, S.
    Lin, W.
    Tagliaferri, M.
    Spigel, D. R.
    ANNALS OF ONCOLOGY, 2019, 30
  • [15] Phase I/II study of DHA–paclitaxel in combination with carboplatin in patients with advanced malignant solid tumours
    M Harries
    A O'Donnell
    M Scurr
    S Reade
    C Cole
    I Judson
    A Greystoke
    C Twelves
    S Kaye
    British Journal of Cancer, 2004, 91 : 1651 - 1655
  • [16] Phase I study on docetaxel and ifosfamide in patients with advanced solid tumours
    Pronk, LC
    Schrijvers, D
    Schellens, JHM
    de Bruijn, EA
    Planting, AST
    Locci-Tonelli, D
    Groult, V
    Verweij, J
    van Oosterom, AT
    BRITISH JOURNAL OF CANCER, 1998, 77 (01) : 153 - 158
  • [17] Phase I study on docetaxel and ifosfamide in patients with advanced solid tumours
    LC Pronk
    D Schrijvers
    JHM Schellens
    EA de Bruijn
    ASTh Planting
    D Locci-Tonelli
    V Groult
    J Verweij
    AT van Oosterom
    British Journal of Cancer, 1998, 77 : 153 - 158
  • [18] A phase I dose-escalation study of the novel peptide ALM201 in patients (pts) with advanced solid tumours
    El-Helali, A.
    Plummer, R.
    Jayson, G.
    Coyle, V.
    Drew, Y.
    Mescallado, N.
    Harris, N.
    Clamp, A.
    McCann, J.
    Kennedy, R.
    Cranston, A.
    Wilson, R.
    ANNALS OF ONCOLOGY, 2017, 28
  • [19] Lurbinectedin (LUR) in combination with irinotecan (IRI) in patients (pts) with advanced solid tumours
    Aix, S. Ponce
    Flor, M. J.
    Falcon, A.
    Sanchez Simon, I.
    Jimenez, E.
    Cote, G.
    Nunez, R.
    Siguero, M.
    Insa, M.
    Cullell-Young, M.
    Kahatt, C.
    Zeaiter, A.
    Paz-Ares, L.
    ANNALS OF ONCOLOGY, 2019, 30
  • [20] Phase I/II study of DHA-paclitaxel in combination with carboplatin in patients with advanced malignant solid tumours
    Harries, M
    O'Donnell, A
    Scurr, M
    Reade, S
    Cole, C
    Judson, I
    Greystoke, A
    Twelves, C
    Kaye, S
    BRITISH JOURNAL OF CANCER, 2004, 91 (09) : 1651 - 1655
12345